Invasive lobular carcinoma of the breast: Patient response to systemic endocrine therapy and hormone response in model systems

Steroids

Volumn 78, Issue 6, 2013, Pages 568-575

  Sikora, Matthew J ^a,b   Jankowitz, Rachel C ^b,c   Dabbs, David J ^b,d   Oesterreich, Steffi ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Breast cancer; Endocrine therapy; Estrogen receptor; Lobular carcinoma

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN; TAMOXIFEN; TUMOR MARKER;

BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RESEARCH; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; GENOMICS; HORMONE RELEASE; HUMAN; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; HUMANS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS;

EID: 84876688456     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.11.002     Document Type: Conference Paper

References (88)

1. A. Bharat, F. Gao, and J.A. Margenthaler Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers Am J Surg 198 2009 516 519
2. E.R. Fisher, R.M. Gregorio, B. Fisher, C. Redmond, F. Vellios, and S.C. Sommers The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4) Cancer 36 1975 1 85
3. M. Cristofanilli, A. Gonzalez-Angulo, N. Sneige, S.-W. Kau, K. Broglio, and R.L. Theriault Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes J Clin Oncol 23 2005 41 48
4. S. Toikkanen, L. Pylkkänen, and H. Joensuu Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma Br J Cancer 76 1997 1234 1240
5. A.I. Phipps, C.I. Li, K. Kerlikowske, W.E. Barlow, and D.S.M. Buist Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population Cancer Epidemiol Biomarkers Prev 19 2010 1643 1654
6. B.C. Pestalozzi, D. Zahrieh, E. Mallon, B.A. Gusterson, K.N. Price, and R.D. Gelber Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials J Clin Oncol 26 2008 3006 3014
7. T.N. Vo, F. Meric-Bernstam, M. Yi, T.A. Buchholz, F.C. Ames, and H.M. Kuerer Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma Am J Surg 192 2006 552 555
8. C.I. Li, B.O. Anderson, P. Porter, S.K. Holt, J.R. Daling, and R.E. Moe Changing incidence rate of invasive lobular breast carcinoma among older women Cancer 88 2000 2561 2569
9. G. Arpino, V.J. Bardou, G.M. Clark, and R.M. Elledge Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome Breast Cancer Res 6 2004 R149 R156
10. N. Biglia, L. Mariani, L. Sgro, P. Mininanni, G. Moggio, and P. Sismondi Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment Endocr Relat Cancer 14 2007 549 567
11. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics CA Cancer J Clin 62 2012 10 29
12. N. Wasif, M.A. Maggard, C.Y. Ko, and A.E. Giuliano Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes Ann Surg Oncol 17 2010 1862 1869
13. X. Sastre-Garau, M. Jouve, B. Asselain, A. Vincent-Salomon, P. Beuzeboc, and T. Dorval Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns Cancer 77 1996 113 120
14. V. Martinez, and J.G. Azzopardi Invasive lobular carcinoma of the breast: incidence and variants Histopathology 3 1979 467 488
15. M. Hussien, T.F. Lioe, J. Finnegan, and R.A.J. Spence Surgical treatment for invasive lobular carcinoma of the breast Breast 12 2003 23 35
16. S.H. Kim, E.S. Cha, C.S. Park, B.J. Kang, I.Y. Whang, and A.W. Lee Imaging features of invasive lobular carcinoma: comparison with invasive ductal carcinoma Jpn J Radiol 29 2011 475 482
17. B. Fernández, E.C. Paish, A.R. Green, A.H.S. Lee, R.D. Macmillan, and I.O. Ellis Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast J Clin Pathol 64 2011 995 1000
18. M. Iorfida, E. Maiorano, E. Orvieto, P. Maisonneuve, L. Bottiglieri, and N. Rotmensz Invasive lobular breast cancer: subtypes and outcome Breast Cancer Res Treat 133 2012 713 723
19. D.J. Dabbs, R. Bhargava, and M. Chivukula Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin Am J Surg Pathol 31 2007 427 437
20. C. Gamallo, J. Palacios, A. Suarez, A. Pizarro, P. Navarro, and M. Quintanilla Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma Am J Pathol 142 1993 987 993
21. R. Moll, M. Mitze, U.H. Frixen, and W. Birchmeier Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas Am J Pathol 143 1993 1731 1742
22. E.A. Rakha, A. Patel, D.G. Powe, A. Benhasouna, A.R. Green, and M.B. Lambros Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast Am J Surg Pathol 34 2010 1472 1479
23. D.J. Dabbs, M. Kaplai, M. Chivukula, A. Kanbour, A. Kanbour-Shakir, and G.J. Carter The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast Appl Immunohistochem Mol Morphol 15 2007 260 266
24. J.S. Reis-Filho, P.T. Simpson, N.C. Turner, M.B. Lambros, C. Jones, and A. Mackay FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas Clin Cancer Res 12 2006 6652 6662
25. D.J. Dabbs Breast pathology 1st ed. 2012 Elsevier Inc. Pittsburgh, PA
26. E. Orvieto, E. Maiorano, L. Bottiglieri, P. Maisonneuve, N. Rotmensz, and V. Galimberti Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution Cancer 113 2008 1511 1520
27. P. Simpson, J. Reis-Filho, M. Lambros, C. Jones, D. Steele, and A. Mackay Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas J Pathol 215 2008 231 244
28. P.W.B. Derksen, T.M. Braumuller, E. van der Burg, M. Hornsveld, E. Mesman, and J. Wesseling Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice Dis Model Mech 4 2011 347 358
29. L. Monhollen, C. Morrison, F.O. Ademuyiwa, R. Chandrasekhar, and T. Khoury Pleomorphic lobular carcinoma: a distinctive clinical and molecular breast cancer type Histopathology 61 2012 365 377
30. T. Sørlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, and H. Johnsen Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 2001 10869 10874
31. F. Bertucci, B. Orsetti, V. Nègre, P. Finetti, C. Rougé, and J.-C.C. Ahomadegbe Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles Oncogene 27 2008 5359 5372
32. B. Weigelt, F.C. Geyer, R. Natrajan, M.A. Lopez-Garcia, A.S. Ahmad, and K. Savage The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type J Pathol 220 2010 45 57
33. B. Weigelt, H.M. Horlings, B. Kreike, M.M. Hayes, M. Hauptmann, and L.F.A. Wessels Refinement of breast cancer classification by molecular characterization of histological special types J Pathol 216 2008 141 150
34. H. Feigelson, A. Onitilo, T. James, E.A. Bowles, R. Single, and T. Barney CA2-04: variation in mastectomy rate for invasive breast cancer: results from the breast cancer surgical outcomes study Clin Med Res 10 2012 151 152
35. D.J. Winchester, H.R. Chang, T.A. Graves, H.R. Menck, K.I. Bland, and D.P. Winchester A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes J Am Coll Surg 186 1998 416 422
36. B. Lau, and L.M. Romero Does preoperative magnetic resonance imaging beneficially alter surgical management of invasive lobular carcinoma? Am Surg 77 2011 1368 1371
37. A. Stivalet, A. Luciani, F. Pigneur, T.H. Dao, P. Beaussart, and Z. Merabet Invasive lobular carcinoma of the breast: MRI pathological correlation following bilateral total mastectomy Acta Radiol 53 2012 367 375
38. S.E. Singletary, L. Patel-Parekh, and K.I. Bland Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base Ann Surg 242 2005 281 289
39. T. Nagao, T. Kinoshita, T. Hojo, H. Tsuda, K. Tamura, and Y. Fujiwara The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics Breast 21 2012 289 295
40. M. Colleoni, L. Russo, and S. Dellapasqua Adjuvant therapies for special types of breast cancer Breast 20 Suppl. 3 2011 S153 S157
41. A. Katz, E.D. Saad, P. Porter, and L. Pusztai Primary systemic chemotherapy of invasive lobular carcinoma of the breast Lancet Oncol 8 2007 55 62
42. E. Brunello, M. Brunelli, E. Manfrin, A. Nottegar, S. Bersani, and M. Vergine Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies Histopathology 60 2012 482 488
43. J.M. Dixon, L. Renshaw, J. Dixon, and J. Thomas Invasive lobular carcinoma: response to neoadjuvant letrozole therapy Breast Cancer Res Treat 130 2011 871 877
44. J. Yu, R. Bhargava, and D.J. Dabbs Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies Diagn Pathol 5 2010 36
45. R. Bhargava, J. Striebel, S. Beriwal, J.C. Flickinger, A. Onisko, and G. Ahrendt Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers Int J Clin Exp Pathol 2 2009 444 455
46. M.S. Moran, Q. Yang, and B.G. Haffty The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology Breast J 15 2009 571 578
47. E.A. Rakha, M.E. El-Sayed, D.G. Powe, A.R. Green, H. Habashy, and M.J. Grainge Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes Eur J Cancer 44 2008 73 83
48. D.B. Smith, A. Howell, and J. Wagstaff Infiltrating lobular carcinoma of the breast: response to endocrine therapy and survival Eur J Cancer Clin Oncol 23 1987 979 982
49. D. Dian, H. Herold, I. Mylonas, C. Scholz, W. Janni, and H. Sommer Survival analysis between patients with invasive ductal and invasive lobular breast cancer Arch Gynecol Obstet 279 2009 23 28
50. L. Fortunato, A. Mascaro, I. Poccia, R. Andrich, M. Amini, and L. Costarelli Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? Analysis of an institutional database over a 10-year period Ann Surg Oncol 19 2012 1107 1114
51. R.J. Santiago, E.E.R. Harris, L. Qin, W.-T. Hwang, and L.J. Solin Similar long-term results of breast-conservation treatment for stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience Cancer 103 2005 2447 2454
52. J.N. Mhuircheartaigh, C. Curran, E. Hennessy, and M.J. Kerin Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma Br J Surg 95 2008 827 833
53. M. Colleoni, N. Rotmensz, P. Maisonneuve, M.G. Mastropasqua, A. Luini, and P. Veronesi Outcome of special types of luminal breast cancer Ann Oncol 23 2012 1428 1436
54. P. Bonnier, S. Romain, P.L. Giacalone, F. Laffargue, P.M. Martin, and L. Piana Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy Obstet Gynecol 85 1995 11 17
55. C.-L. Chen Hormone replacement therapy in relation to breast cancer JAMA 287 2002 734 741
56. C.I. Li, N.S. Weiss, J.L. Stanford, and J.R. Daling Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women Cancer 88 2000 2570 2577
57. I.F. O'Connor, M.V. Shembekar, and S. Shousha Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study J Clin Pathol 51 1998 935 938
58. C.I. Li, B.O. Anderson, J.R. Daling, and R.E. Moe Trends in incidence rates of invasive lobular and ductal breast carcinoma JAMA 289 2003 1421 1424
59. P.A. Newcomb, L. Titus-Ernstoff, K.M. Egan, A. Trentham-Dietz, J.A. Baron, and B.E. Storer Postmenopausal estrogen and progestin use in relation to breast cancer risk Cancer Epidemiol Biomarkers Prev 11 2002 593 600
60. L.M. Newcomer, P.A. Newcomb, J.D. Potter, Y. Yasui, A. Trentham-Dietz, and B.E. Storer Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States) Cancer Causes Control 14 2003 225 233
61. J. Kotsopoulos, W.Y. Chen, M.A. Gates, S.S. Tworoger, S.E. Hankinson, and B.A. Rosner Risk factors for ductal and lobular breast cancer: results from the nurses' health study Breast Cancer Res 12 2010 R106
62. P.E. Goss, J.N. Ingle, J.E. Alés-Martínez, A.M. Cheung, R.T. Chlebowski, and J. Wactawski-Wende Exemestane for breast-cancer prevention in postmenopausal women N Engl J Med 364 2011 2381 2391
63. R. Cailleau, R. Young, M. Olivé, and W.J. Reeves Breast tumor cell lines from pleural effusions J Natl Cancer Inst 53 1974 661 674
64. R. Cailleau, M. Olivé, and Q.V. Cruciger Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization In Vitro 14 1978 911 915
65. M. Lacroix, and G. Leclercq Relevance of breast cancer cell lines as models for breast tumours: an update Breast Cancer Res Treat 83 2004 249 289
66. R. Brough, J.R. Frankum, D. Sims, A. Mackay, A.M. Mendes-Pereira, and I. Bajrami Functional viability profiles of breast cancer Cancer Discov 1 2011 260 273
67. R.M. Neve, K. Chin, J. Fridlyand, J. Yeh, F.L. Baehner, and T. Fevr A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Cancer Cell 10 2006 515 527
68. S.W. McLeskey, I.Y. Ding, M.E. Lippman, and F.G. Kern MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands Cancer Res 54 1994 523 530
69. S.P. Ethier, M.L. Mahacek, W.J. Gullick, T.S. Frank, and B.L. Weber Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media Cancer Res 53 1993 627 635
70. M. van de Wetering, N. Barker, I.C. Harkes, M. van der Heyden, N.J. Dijk, and A. Hollestelle Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling Cancer Res 61 2001 278 284
71. Z.-Q. Yang, D. Albertson, and S.P. Ethier Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines Cancer Genet Cytogenet 155 2004 57 62
72. G.C. Reiner, and B.S. Katzenellenbogen Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells Cancer Res 46 1986 1124 1131
73. R.B. Riggins, J.P.-J. Lan, Y. Zhu, U. Klimach, A. Zwart, and L.R. Cavalli ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer Cancer Res 68 2008 8908 8917
74. A.F. Gazdar, V. Kurvari, A. Virmani, L. Gollahon, M. Sakaguchi, and M. Westerfield Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer 78 1998 766 774
75. M. Christgen, H. Bruchhardt, C. Hadamitzky, C. Rudolph, D. Steinemann, and D. Gadzicki Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer J Pathol 217 2009 620 632
76. P.W.B. Derksen, X. Liu, F. Saridin, H. van der Gulden, J. Zevenhoven, and B. Evers Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis Cancer Cell 10 2006 437 449
77. K. Günther, S. Merkelbach-Bruse, B.K. Amo-Takyi, S. Handt, W. Schröder, and L. Tietze Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization J Pathol 193 2001 40 47
78. N. Gruel, C. Lucchesi, V. Raynal, M.J. Rodrigues, G. Pierron, and R. Goudefroye Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma Eur J Cancer 46 2010 2399 2407
79. A.N. Brooks, E. Kilgour, and P.D. Smith Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer Clin Cancer Res 18 2012 1855 1862
80. R.R. Reddel, L.C. Murphy, R.E. Hall, and R.L. Sutherland Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen Cancer Res 45 1985 1525 1531
81. G. Turashvili, J. Bouchal, K. Baumforth, W. Wei, M. Dziechciarkova, and J. Ehrmann Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis BMC Cancer 7 2007 55
82. E.S. Hwang, S.J. Nyante, Y. Yi Chen, D. Moore, S. DeVries, and J.E. Korkola Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma Cancer 100 2004 2562 2572
83. H. Zhao, A. Langerod, Y. Ji, K.W. Nowels, J.M. Nesland, and R. Tibshirani Different gene expression patterns in invasive lobular and ductal carcinomas of the breast Mol Biol Cell 15 2004 2523 2536
84. J.E. Korkola, S. DeVries, J. Fridlyand, E.S. Hwang, A.L.H. Estep, and Y.-Y.Y. Chen Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis Cancer Res 63 2003 7167 7175
85. S.P. Shah, R.D. Morin, J. Khattra, L. Prentice, T. Pugh, and A. Burleigh Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution Nature 461 2009 809 813
86. F. Wu, I. Ivanov, R. Xu, and S. Safe Role of SP transcription factors in hormone-dependent modulation of genes in MCF-7 breast cancer cells: microarray and RNA interference studies J Mol Endocrinol 42 2009 19 33
87. C. Curtis, S.P. Shah, S.-F. Chin, G. Turashvili, O.M. Rueda, and M.J. Dunning The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups Nature 486 2012 346 352
88. M.J. Ellis, L. Ding, D. Shen, J. Luo, V.J. Suman, and J.W. Wallis Whole-genome analysis informs breast cancer response to aromatase inhibition Nature 486 2012 353 360